Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about IR: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | IR |
| Key Genes/Proteins | AKT, ALOX12, AMPK, ANGPT1, ATM, BACE1 |
| Related Diseases | Alzheimer's disease, diabetes |
| Related Pathways | apoptosis pathway, blood-brain barrier |
| Linked Hypotheses | 30 hypotheses |
Knowledge base pages for this entity
graph TD
IR[IR]
IR -->|activates| neuroinflammation[neuroinflammation]
IR -->|expressed in| macrophages[macrophages]
IR -->|activates| PI3K[PI3K]
IR -->|activates| neurodegeneration[neurodegeneration]
IR -->|interacts| MAP2[MAP2]
IR -->|activates| NLRP3[NLRP3]
IR -->|activates| TNF[TNF]
IR -->|activates| stroke[stroke]
IR -->|activates| MET[MET]
DNA[DNA] -->|inhibits| IR
AKT[AKT] -->|activates| IR
GFAP[GFAP] -->|implicated in| IR
BACE1[BACE1] -->|activates| IR
CERS2[CERS2] -->|activates| IR
ALOX12[ALOX12] -->|implicated in| IR
ANGPT1[ANGPT1] -->|activates| IR
HDAC3[HDAC3] -->|activates| IR| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:IR | data_in | dataset_row | 0.00 |
| neuroinflammation | activates | disease | 0.70 |
| macrophages | expressed_in | cell_type | 0.70 |
| NLRP3 | activates | gene | 0.60 |
| TNF | activates | gene | 0.60 |
| stroke | activates | disease | 0.60 |
| MET | activates | gene | 0.60 |
| MET | biomarker_for | gene | 0.60 |
| PSEN1 | regulates | gene | 0.60 |
| neurodegeneration | interacts_with | disease | 0.60 |
| neuroinflammation | interacts_with | disease | 0.60 |
| neuroinflammation | associated_with | disease | 0.60 |
| ferroptosis | participates_in | pathway | 0.60 |
| TGM2 | inhibits | gene | 0.60 |
| neurodegeneration | inhibits | disease | 0.60 |
| LRP2 | targets | gene | 0.60 |
| LRP2 | regulates | gene | 0.60 |
| TH | expressed_in | gene | 0.60 |
| JNK | activates | gene | 0.60 |
| NBS1 | inhibits | gene | 0.60 |
| PARP1 | inhibits | gene | 0.60 |
| RAD51 | inhibits | gene | 0.60 |
| Alzheimer's disease | associated_with | disease | 0.60 |
| diabetes | associated_with | disease | 0.60 |
| oxidative stress response | participates_in | pathway | 0.60 |
| diabetes | activates | disease | 0.60 |
| PI3K-AKT-mTOR signaling | participates_in | pathway | 0.60 |
| LDL | associated_with | gene | 0.60 |
| synaptic plasticity | participates_in | pathway | 0.60 |
| neurodegeneration | associated_with | disease | 0.60 |
| neurodegeneration | activates | disease | 0.60 |
| MAP2 | interacts_with | gene | 0.60 |
| MAPK signaling | participates_in | pathway | 0.60 |
| RNA | interacts_with | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| diabetes | protects_against | disease | 0.60 |
| PINK | activates | gene | 0.60 |
| pyroptosis | participates_in | pathway | 0.60 |
| Alzheimer's disease | activates | disease | 0.60 |
| apoptosis pathway | participates_in | pathway | 0.60 |
| senescence | participates_in | pathway | 0.60 |
| TGF | interacts_with | gene | 0.60 |
| TGF-beta signaling | participates_in | pathway | 0.60 |
| ubiquitin-proteasome | participates_in | pathway | 0.60 |
| blood-brain barrier | participates_in | pathway | 0.60 |
| astrocytes | expressed_in | cell_type | 0.55 |
| microglia | expressed_in | cell_type | 0.55 |
| neurons | expressed_in | cell_type | 0.55 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:IR | data_in | dataset_row | 0.00 |
| CLCN1 | associated_with | gene | 0.70 |
| DNA | inhibits | gene | 0.70 |
| CP | associated_with | gene | 0.60 |
| ALOX12 | associated_with | gene | 0.60 |
| ANGPT1 | activates | gene | 0.60 |
| HDAC3 | activates | gene | 0.60 |
| HDAC3 | protects_against | gene | 0.60 |
| HDAC3 | associated_with | gene | 0.60 |
| HDAC3 | inhibits | gene | 0.60 |
| HIF | activates | gene | 0.60 |
| metformin | targets | drug | 0.60 |
| DNA | activates | gene | 0.60 |
| rapamycin | targets | drug | 0.60 |
| DNA | implicated_in | gene | 0.60 |
| CERS2 | activates | gene | 0.60 |
| DNA | interacts_with | gene | 0.60 |
| GFAP | implicated_in | gene | 0.60 |
| GFAP | interacts_with | gene | 0.60 |
| BACE1 | activates | gene | 0.60 |
| H2AX | activates | gene | 0.60 |
| H2AX | associated_with | gene | 0.60 |
| ATM | inhibits | gene | 0.60 |
| AMPK | activates | gene | 0.60 |
| INS | biomarker_for | gene | 0.60 |
| AKT | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs AD with Co | clinical | Alzheimer's Disease | 0.900 | 0.50 | aortic endothelial cells | proposed | $6,550,000 |
| Irisin effects on osteogenic differentiation in mesenchymal stem cells | exploratory | bone fracture | 0.900 | 0.00 | mouse bone mesenchymal stem ce | proposed | N/A |
| Microglial SIRPα expression in human Alzheimer's disease tissue | exploratory | Alzheimer's disease | 0.800 | 0.00 | human brain tissue | proposed | N/A |
| Anti-miR-155 LNA Oligonucleotide Shifts Microglia to Homeostatic State | in_vivo | neurodegeneration | 0.774 | 0.65 | C57BL/6J LPS model (chronic i. | proposed | $58,000 |
| Sequential DFO + Sulforaphane Prevents Iron-Ferroptosis Cascade in Rat | in_vivo | post-cardiac-arrest neurodegen | 0.768 | 0.72 | Sprague-Dawley rat asphyxial c | abandoned | $48,000 |
| s:** - Test tau spreading in AQP4 knockout vs wild-type mice with PSP/ | falsification | Neurodegeneration | 0.400 | 0.50 | mouse | proposed | $260,000 |
| Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Trial | clinical | Neurodegeneration | 0.400 | 0.50 | human | proposed | $3,900,000 |
| DLB Cognitive Fluctuation Mechanism Experiment | clinical | Neurodegeneration | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Glymphatic-Circadian Axis Enhancement Therapy for Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Non-Motor Symptom Progression in Parkinson's Disease — Mechanisms and | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| NPH Glymphatic System Interaction Experiment | clinical | Neurodegeneration | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Sleep and Circadian Dysfunction as Driver of Neurodegeneration | clinical | Neurodegeneration | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Sleep Disruption and Alzheimer's Disease — mechanism and intervention | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Sleep and Respiratory Network Interaction in ALS — Experiment Design | clinical | ALS | 0.400 | 0.50 | human | proposed | $5,460,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Combined effects of HCRTR1/2 gene variants and non-genetic factors on sleep-wake [PMID:40439868] | Zheng Z, Xue F, Wang H, Gu Q, Hu R, Li X | Pharmacol Rep | 2025 | 1 |
| Genetic determinants of daytime napping and effects on cardiometabolic health. [PMID:33568662] | Dashti HS, Daghlas I, Lane JM, Huang Y, | Nat Commun | 2021 | 1 |
| Hypocretin/Orexin Receptor Pharmacology and Sleep Phases. [PMID:34052813] | Sun Y, Tisdale RK, Kilduff TS | Front Neurol Neurosci | 2021 | 1 |
| Sleep drives metabolite clearance from the adult brain. [PMID:24136970] | Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Th | Science | 2013 | 1 |
| Changes in Circulating Levels of miR-30b During Minipuberty and Puberty in Girls [PMID:40899010] | Albrechtsen HM, Saritas G, Winge SB, Mai | J Clin Endocrinol Metab | 2026 | 0 |
| Epigenetics in chronic rhinosinusitis. [PMID:41442742] | Kumar N, Brar T, Lal D | Curr Opin Otolaryngol Head Nec | 2026 | 0 |
| Extracellular vesicles in type 2 diabetes exhibit elevated miR-155 cargo and Ann [PMID:41786286] | Jackson G, Islam H, de Souza Teixeira AA | Life Sci | 2026 | 0 |
| Decoding microRNA-Protein Interaction Networks in Alzheimer's Disease: Molecular [PMID:41918207] | Mishra R, Gupta JK | Curr Alzheimer Res | 2026 | 0 |
| Di-2-ethylhexylphthalate-induced miR155-5P promotes placental ferroptosis. [PMID:41937013] | Gu X, Sun F, Li Y, Yang S, Li Y | Int J Biol Macromol | 2026 | 0 |
| Extracellular Vesicles in Obesity: From Pathophysiological Mediators to Therapeu [PMID:41977323] | Pavlović N, Todorović P, Maglica M, Kopi | Int J Mol Sci | 2026 | 0 |
| Decoding microRNA-Protein Interaction Networks in Alzheimer's Disease: Molecular [PMID:41918207] | Mishra R, Gupta JK | Current Alzheimer research | 2026 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Signal transduction, dimerization, and therapeutic targeting of Orexin and recep [PMID:41383480] | Zhang S, Wang P, Ji B, Shao Y, Hou S et | Front Pharmacol | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Increased Neuronal Expression of the Early Endosomal Adaptor APPL1 Replicates Al [PMID:40514243] | Jiang Y, Sachdeva K, Goulbourne CN, Berg | The Journal of neuroscience : | 2025 | 0 |
| Bioinformatic analysis of neuropeptide related genes in patients diagnosed with [PMID:39437604] | Yay F, Ayan D | Comput Biol Med | 2024 | 0 |
| Effects of Paradoxical Sleep Deprivation on MCH and Hypocretin Systems. [PMID:39698172] | Agamme ALDA, Tufik S, Torterolo P, D'Alm | Sleep science (Sao Paulo, Braz | 2024 | 0 |
| Blast Exposure Induces Acute Alterations in Circadian Clock Genes in the Hypotha [PMID:41127649] | Govindarajulu M, Patel MY, Krishnan J, L | Neurotrauma reports | 2023 | 0 |
| Contextual generalization of social stress learning is modulated by orexin recep [PMID:35724928] | Yaeger JDW, Krupp KT, Summers TR, Summer | Neuropharmacology | 2022 | 0 |
| Evaluation of the α-casein (CSN1S1) locus as a potential target for a site-speci [PMID:35568783] | ["Smirnov A", "Kontsevaya G", "Shnaider | Scientific reports | 2022 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning IR in their description or question text
Score: 0.843 · neurodegeneration · 2026-04-16
## Mechanistic Overview miR-155/Interferon-gamma Feedback Loop as a Reversible Molecular Switch for Protective Microglia
Score: 0.838 · neurodegeneration · 2026-04-17
## Mechanistic Overview Sequential Iron Chelation (Deferoxamine) and GPX4 Restoration (Sulforaphane) Prevents the Self-A
Score: 0.826 · alzheimers · 2026-04-28
Auditory 40 Hz entrainment applied during NREM sleep consolidates temporal coupling between hippocampal theta oscillatio
Score: 0.824 · molecular-biology · 2026-04-16
## Mechanistic Overview miR-33 Antisense Oligonucleotide Hyper-Lipidation Strategy starts from the claim that modulating
Score: 0.824 · neurodegeneration · 2026-04-17
## Mechanistic Overview SIRT1 Activation Couples Mitochondrial Biogenesis to Ferroptosis Suppression via PGC1alpha-Depen
Score: 0.820 · alzheimers · 2026-04-02
## Mechanistic Overview Hippocampal CA3-CA1 circuit rescue via neurogenesis and synaptic preservation starts from the cl
Score: 0.815 · protein-folding · 2026-04-22
**Molecular Mechanism and Rationale** The therapeutic hypothesis centers on the kinetic constraints governing chaperone
Score: 0.813 · synaptic-biology · 2026-04-21
## Mechanistic Overview TREM2-Dependent Switch Hypothesis: TREM2 Agonism Redirects SPP1 Signaling from Destructive to Re
Score: 0.811 · alzheimers · 2026-04-05
## Mechanistic Overview Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and block tau propagat
Score: 0.790 · neurodegeneration · 2026-04-22
## Mechanistic Overview NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic Axis and Dopaminergic Neuron Survival
Score: 0.778 · neurodegeneration · 2026-04-16
## Mechanistic Overview SIRT1/PGC-1α Axis Activation to Preserve Mitochondrial Resiliency Against Microbiome-Induced Neu
Score: 0.775 · alzheimers · 2026-04-02
## Molecular Mechanism and Rationale Parvalbumin-expressing (PV+) interneurons represent the most abundant class of GAB
Score: 0.775 · alzheimers · 2026-04-12
## Mechanistic Overview Alpha-gamma cross-frequency coupling enhancement to restore thalamo-cortical memory circuits sta
Score: 0.774 · neuroscience · 2026-04-07
## Mechanistic Overview Dual-Circuit Tau Vulnerability Cascade starts from the claim that modulating MAPT within the dis